TriSalus Life Sciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 133.38 K | $736.26 K | 65.61% | 0.50% |
MSD PARTNERS, L.P. | 05/15/2025 | 40.00 K | $220.79 K | 0.00% | 0.15% |
SRS CAPITAL ADVISORS, INC. | 05/15/2025 | 4.01 K | $22.13 K | 100.00% | 0.02% |
ANGELO GORDON & CO., L.P. | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
WOLVERINE ASSET MANAGEMENT LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
DUQUESNE FAMILY OFFICE LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
EXOS ASSET MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
TriSalus Life Sciences, Inc. institutional Ownership - FAQ's
During the previous two years, 13 institutional investors and hedge funds held shares of TriSalus Life Sciences, Inc.. The most heavily invested institutionals were:
MILLENNIUM MANAGEMENT LLC: 133,380
MSD Partners, L.P.: 39,999
SRS Capital Advisors, Inc.: 4,008
ANGELO GORDON & CO., L.P.: 0
Duquesne Family Office LLC: 0
Exos Asset Management LLC: 0
0.02% of TriSalus Life Sciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 399.50 K shares in the last 24 months. This purchase volume represents approximately $2.15 M in transactions.